DNB Carnegie acted as joint bookrunner in SEK 3.1 billion placing of shares in Asker, on behalf of the Sixth AP-fund.
Asker is a leading provider of medical products and solutions in Europe. Asker has organically and via acquisitions built a pan-European group with deep knowledge in healthcare, attracting entrepreneurs that together with the Company want to drive progress and support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain.